Matches in Wikidata for { <http://www.wikidata.org/entity/Q92499417> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q92499417 description "article scientifique publié en 2019" @default.
- Q92499417 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92499417 description "scientific article published on 01 June 2019" @default.
- Q92499417 description "wetenschappelijk artikel" @default.
- Q92499417 description "наукова стаття, опублікована 1 червня 2019" @default.
- Q92499417 name "Octanorm [cutaquig®], a new immunoglobulin (human) subcutaneous 16.5% solution for injection (165 mg/mL) - Biochemical characterization, pathogen safety, and stability" @default.
- Q92499417 name "Octanorm [cutaquig®], a new immunoglobulin (human) subcutaneous 16.5% solution for injection (165 mg/mL) - Biochemical characterization, pathogen safety, and stability" @default.
- Q92499417 type Item @default.
- Q92499417 label "Octanorm [cutaquig®], a new immunoglobulin (human) subcutaneous 16.5% solution for injection (165 mg/mL) - Biochemical characterization, pathogen safety, and stability" @default.
- Q92499417 label "Octanorm [cutaquig®], a new immunoglobulin (human) subcutaneous 16.5% solution for injection (165 mg/mL) - Biochemical characterization, pathogen safety, and stability" @default.
- Q92499417 prefLabel "Octanorm [cutaquig®], a new immunoglobulin (human) subcutaneous 16.5% solution for injection (165 mg/mL) - Biochemical characterization, pathogen safety, and stability" @default.
- Q92499417 prefLabel "Octanorm [cutaquig®], a new immunoglobulin (human) subcutaneous 16.5% solution for injection (165 mg/mL) - Biochemical characterization, pathogen safety, and stability" @default.
- Q92499417 P1433 Q92499417-ACC6AFFC-DFBC-416F-BB46-112D568AD191 @default.
- Q92499417 P1476 Q92499417-063C17E9-FF8A-4332-85E5-4415DA4A5CB3 @default.
- Q92499417 P2093 Q92499417-04833D63-E805-48BB-A976-B36FF8FFDD89 @default.
- Q92499417 P2093 Q92499417-0D1D91BC-8F6E-4347-8434-6FA8ED9584BA @default.
- Q92499417 P2093 Q92499417-1D018C06-99AD-4889-A0D1-2FBCB6919E4C @default.
- Q92499417 P2093 Q92499417-41C2F331-8559-4F7A-941F-31C5F08410E5 @default.
- Q92499417 P2093 Q92499417-8A20655E-DE3C-409D-91A8-EED70991AC4E @default.
- Q92499417 P2093 Q92499417-A2B2961A-A69D-4A3C-87EF-7F8EBFFA5D56 @default.
- Q92499417 P2093 Q92499417-BC1BB8BB-6992-465F-96ED-7114F264F2F5 @default.
- Q92499417 P2093 Q92499417-CD7F42F8-6D3D-4412-A196-CABCB4B6CBB5 @default.
- Q92499417 P2860 Q92499417-50161A19-0818-4B1B-B704-47969E11FEE5 @default.
- Q92499417 P304 Q92499417-419658D3-87A0-42A7-A6A9-3B4C198644D9 @default.
- Q92499417 P31 Q92499417-A8989E7A-D661-4573-A7EC-FC6482E86DDD @default.
- Q92499417 P356 Q92499417-2AC90205-53AF-40D8-B4BF-AB1D2B64F63E @default.
- Q92499417 P478 Q92499417-323B2D14-C2D3-434F-B2BA-7F359CB40DE8 @default.
- Q92499417 P577 Q92499417-6E881126-9C30-4939-B9E7-B04EFF3CE71B @default.
- Q92499417 P698 Q92499417-0A83795F-DA30-4DAF-A247-5ED9C2971D38 @default.
- Q92499417 P356 J.BIOLOGICALS.2019.05.002 @default.
- Q92499417 P698 31160148 @default.
- Q92499417 P1433 Q4915041 @default.
- Q92499417 P1476 "Octanorm [cutaquig®], a new immunoglobulin (human) subcutaneous 16.5% solution for injection (165 mg/mL) - Biochemical characterization, pathogen safety, and stability" @default.
- Q92499417 P2093 "Alexander Pichotta" @default.
- Q92499417 P2093 "Alfred Zöchling" @default.
- Q92499417 P2093 "Andrej Murányi" @default.
- Q92499417 P2093 "Jürgen Römisch" @default.
- Q92499417 P2093 "Katharina Pock" @default.
- Q92499417 P2093 "Nicola Gelbmann" @default.
- Q92499417 P2093 "Thomas Ernegger" @default.
- Q92499417 P2093 "Torben Schmidt" @default.
- Q92499417 P2860 Q28114690 @default.
- Q92499417 P304 "60-67" @default.
- Q92499417 P31 Q13442814 @default.
- Q92499417 P356 "10.1016/J.BIOLOGICALS.2019.05.002" @default.
- Q92499417 P478 "60" @default.
- Q92499417 P577 "2019-06-01T00:00:00Z" @default.
- Q92499417 P698 "31160148" @default.